Latest New Zealand News

Nimy Resources has launched a $2.5 million Share Purchase Plan offering shares at a 15.28% discount to eligible shareholders, aiming to accelerate copper exploration and finalize a gallium resource.

Cochlear Limited has updated its dividend details, confirming a fully franked ordinary dividend of AUD 2.15 per share for the first half of 2025, with payments available in multiple currencies based on shareholder location.

Santana Minerals has reported a significant high-grade gold intercept extending the Rise and Shine deposit 250 metres down plunge, suggesting a potentially much larger orebody and longer mine life.

Woolworths Group Limited has updated its dividend details, confirming a fully franked 45 cent per share payout for the first half of FY25 and setting the Dividend Reinvestment Plan price at $27.78.

Kogan.com Ltd has announced a fully franked ordinary dividend of 7 cents per share for the six months ending June 2025, alongside details of its Dividend Reinvestment Plan pricing.

Endeavour Group Limited has updated its dividend distribution details for the financial period ending June 2025, confirming a fully franked ordinary dividend and outlining currency options and reinvestment plan terms.

Summerset Group Holdings Limited has confirmed an ordinary dividend of NZD 0.113 per security for the half-year ending December 2025, alongside key updates to its Dividend Reinvestment Plan pricing and Australian dollar exchange rate.

Generation Development Group Limited has updated its Dividend Reinvestment Plan price to AUD 6.70 per share, accompanying a fully franked ordinary dividend of 1 cent per share for the half-year ending June 2025.

Resimac Group has successfully settled a A$1 billion non-conforming residential mortgage backed securities transaction, marking its second such bond issuance this year. The deal attracted strong domestic and offshore investor interest, reinforcing Resimac’s diversified funding strategy.

GR Engineering Services Limited has updated its dividend details for the first half of FY2025, declaring a fully franked dividend of 12 cents per share and setting the Dividend Reinvestment Plan price at AUD 3.897 with a 2.5% discount.

BCAL Diagnostics has partnered with US-based ClearNote Health to exclusively distribute innovative blood tests for early detection of pancreatic and ovarian cancers in Australia and New Zealand, starting early 2026.

Imricor Medical Systems has successfully completed a comprehensive Human Factors study for all its devices under FDA review, marking a critical milestone towards U.S. market entry. The extensive 7-month study involved 46 healthcare professionals and tested nine products, underscoring Imricor’s growing momentum in electrophysiology innovation.